Close
What would you like to look for?
Site search
Search filters

RetinAI acquired by EssilorLuxottica

22 October 2025

EssilorLuxottica, a global leader in vision care and eyewear, has acquired Ikerian AG, a health technology company operating under the RetinAI brand, specializing in AI and data management in eyecare.

VISCHER advised Blue Owl in connection with the USD 500 m financing to Madrigal Pharmaceuticals

2 October 2025

VISCHER advised Blue Owl on all Swiss legal aspects of the financing transaction, including an up to USD 500 million term loan facility for Madrigal Pharmaceuticals.

AutoScout24 integrates the C2B business from CARAUKTION

9 September 2025

VISCHER advised CARAUKTION on the takeover of the C2B business division, including the C2B auction platform, by AutoScout24.

Schivo acquires Mecaplast SA

4 September 2025

VISCHER advised Schivo on the acquisition of Mecaplast SA.

VISCHER advised LOOMIS AB in its acquisition of Kipfer Logistik GmbH

12 August 2025

VISCHER advised LOOMIS AB in its acquisition of Kipfer Logistik GmbH, a Switzerland-based logistics company specializing in temperature-controlled transport and storage in the pharmaceutical sector.

Claraspital Basel is being acquired by University Hospital Basel

4 August 2025

The University Hospital Basel (USB), one of Switzerland's leading university hospitals, is acquiring St. Claraspital AG, a leading, systemically important hospital in north-western Switzerland, from St. Clara AG and the Ingenbohl Monastery.

VISCHER advised Picanol in its acquisition of Osterwalder

30 June 2025

Tessenderlo Group, through its group company Picanol NV, has acquired the activities of Osterwalder AG, a Swiss manufacturer of electric powder presses.

Easternmed Real Estate Capital PLC acquires a luxury hotel residence

19 June 2025

VISCHER advised Easternmed Real Estate Capital PLC in its acquisition of a new prime commercial property (hotel residence) in one of the most illustrious streets in Geneva.

Mosanna Therapeutics raises USD 80m in Series-A-Funding

11 June 2025

Mosanna Therapeutics AG closed its USD 80m Series A funding round.

Thommen Group acquires Wiederkehr Group

5 June 2025

Thommen Group acquires 100% of the shares in Wiederkehr Recycling AG (Waltenschwil AG), AVO Wiederkehr AG (Schwarzenbach SG), SMV Wiederkehr Recycling GmbH (Lauchringen, Germany) and the companies Wierec Trading AG (Hünenberg, Zug) and Wierec Services GmbH (Waltenschwil AG), which also belong to the Wiederkehr Group.